Cesca Therapeutics CEO Chris Xu's 2020 pay jumps 323% to $2M
Cesca Therapeutics reports 2020 executive compensation
By ExecPay News
Published: November 5, 2021
Cesca Therapeutics reported fiscal year 2020 executive compensation information on November 5, 2021.
In 2020, two executives at Cesca Therapeutics received on average a compensation package of $1.2M, a 382% increase compared to previous year.
Average pay of disclosed executives at Cesca Therapeutics
Chris Xu, Chief Executive Officer, received $2M in total, which increased by 323% compared to 2019. 61% of Xu's compensation, or $1.2M, was in option awards. Xu also received $276K in bonus and $505K in salary.
Jeffery Cauble, Chief Financial Officer, received a compensation package of $447K, which increased by 101% compared to previous year. 55% of the compensation package, or $244K, was in salary.
Related executives
You may also like
Source: SEC filing on November 5, 2021.